Published by ChinaMNC · Yaoan

Yunnan Unveils 15th Five-Year Plan for Traditional Chinese Medicine Materials: What Foreign Founders Need to Know

Yunnan Province has released its 15th Five-Year Plan for the traditional Chinese medicine (TCM) materials industry, targeting reduced planting area but higher output value by 2030. For foreign founders, this signals opportunities in GAP bases, processing, and health products. Here’s a practical breakdown of the plan and what it means for setting up or expanding a China company.

Yunnan’s TCM Materials Plan: Key Takeaways for Foreign Founders

Yunnan Province has published its 15th Five-Year Plan for the Traditional Chinese Medicine Materials Industry, outlining goals and priorities through 2030. While the plan focuses on industry development, it also creates a framework that foreign founders should understand when considering a China company registration—especially if they plan to operate in agriculture, processing, or health products. Below are the practical implications, drawn strictly from the official source.

1. Reduced Planting Area, Higher Value: A Shift in Strategy

By 2030, Yunnan expects the TCM materials planting area to decrease by 1.608 million mu (approximately 107,200 hectares). At the same time, the comprehensive output value is targeted to increase by 50 billion RMB. This “reduce area, increase quality, processing, branding, and efficiency” approach means the province is prioritizing high-quality, high-value production over volume. For foreign founders, this suggests opportunities in value-added processing and brand development rather than raw material cultivation at scale.

2. Priority Varieties: What to Focus On

Building on the 156 varieties listed in the Yunnan Dao-di Medicinal Materials Catalogue (2024 Edition), the plan emphasizes three categories:

• Dao-di advantage varieties: Led by Panax notoginseng (sanqi), the “Top Ten Yunnan Medicines” include Chonglou (Paris polyphylla), Erigeron breviscapus, Dendrobium officinale, Amomum villosum, Gastrodia elata, Poria cocos, Angelica sinensis, Aucklandia lappa, and Gentiana rigescens.
• Health-characteristic varieties: The “Top Ten Health Resources” include Polygonatum kingianum, safflower, Bletilla striata, Dendrobium devonianum, Phyllanthus emblica, Coix seed, Terminalia chebula, Amomum tsaoko, ginger, and star anise.
• Potential cultivation varieties: The “Six Southern Medicines” include Amomum villosum, dragon’s blood, Cibotium barometz, agarwood, Orthosiphon aristatus, and Dai Bai Jie.

For foreign investors, these categories indicate where government support and market demand are likely to be concentrated. If your China company plans to engage in TCM materials, aligning with these priority varieties could be advantageous.

3. GAP Bases: Compliance and Opportunities

The plan aims to establish 200 GAP (Good Agricultural Practice) bases for TCM materials. Key focuses include full GAP coverage for Wenshan sanqi and orderly development of GAP bases for forest-grown varieties such as Poria, Amomum, tsaoko, and Phellodendron. It also seeks to create national-level high-standard TCM material production bases.

For foreign founders, GAP certification is increasingly important for supplying high-quality materials. Establishing or partnering with GAP bases may require compliance with Chinese agricultural regulations, but it can also open doors to premium markets.

4. Forest-based Cultivation: Expanding Ecological Planting

Focusing on dao-di herbs like sanqi, Gastrodia, Poria, Amomum, Polygonatum, and Phellodendron, the plan promotes forest-based cultivation and targets expanding ecological and forest planting bases to over 6 million mu. This approach aligns with sustainable practices and may offer opportunities for foreign companies with expertise in ecological agriculture.

5. Primary Processing: Upgrading from Raw Materials

The plan supports establishing primary processing lines in dao-di production areas and high-standard bases. It encourages linking GAP base materials with fresh-cut processing and upgrading products from raw materials to semi-industrialized inputs. For foreign founders, this signals a move toward more standardized, higher-value intermediate goods—potentially reducing reliance on raw exports and creating opportunities for processing joint ventures.

6. High-Value Products: Deep Processing and Health Products

Enterprises are encouraged to build modern deep-processing lines and develop high-value products, forming a series of “Yun药” (Yunnan medicine) health products. The plan also promotes R&D and industrialization of daily chemical and functional health products.

This is a clear invitation for foreign companies with expertise in cosmetics, health supplements, or functional foods to consider setting up operations in Yunnan. However, note that producing health products in China typically requires specific licenses (e.g., health food registration), which should be factored into your company setup plan.

7. Market Stabilization: Managing Risks

For bulk and scarce varieties prone to market fluctuations—such as sanqi, Angelica, and Chonglou—the plan emphasizes market-based adjustment mechanisms and an information monitoring and early-warning system to prevent “blind expansion” and “price collapses hurting farmers.” Foreign founders should be aware that market interventions may occur, and building flexibility into supply contracts is advisable.

8. Food-Medicine Homology: New Product Opportunities

The plan includes developing standards for food-medicine homologous raw materials and production processes, completing cross-border registration of 5–10 new products, and planning a “Yun Medicine Food-Medicine Homology Culture Festival.” For foreign founders, this suggests emerging opportunities in cross-border e-commerce and product registration, particularly for items that can be positioned as both food and medicine.

9. “Yun Medicine Brain”: AI and Smart Solutions

An AI innovation project called “Yun Medicine Brain” aims to build an intelligent application system covering the entire lifecycle of TCM materials. While this is a government-led initiative, it may eventually provide data and tools that foreign companies can leverage for quality control and traceability.

What This Means for Your China Company Registration

While the plan itself does not alter company registration procedures, it highlights sectors where Yunnan Province is focusing its support. Foreign founders considering a China company in TCM materials, processing, or health products should:

• Choose the right entity: A wholly foreign-owned enterprise (WFOE) or joint venture (JV) are common options. For agricultural projects, a JV with a local partner may facilitate land access and regulatory compliance.
• Understand licensing: Depending on activities, you may need permits for agricultural production, food production, or health food registration. The plan’s emphasis on GAP and processing suggests that relevant certifications will be important.
• Leverage local incentives: While not detailed in the source, priority industries often benefit from local government support. Engage with local authorities to explore possibilities.
• Plan for compliance: The plan’s focus on quality and standards means that regulatory compliance will be key to success.

For assistance with company registration and navigating these opportunities, foreign founders can contact ChinaMNC on WhatsApp / WeChat at +86 153 1898 8535. Our team can help you set up and operate a company in China, ensuring you meet all legal and regulatory requirements.

This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.